Matti Kankainen

University of Helsinki — Finland

Medicine · Health Sciences

37h-index5.1kcitations190works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(24), Immune Cell Function and Interaction(21), CAR-T cell therapy research(21), Chronic Lymphocytic Leukemia Research(16), Chronic Myeloid Leukemia Treatments(13)

Publications189 total

Platelet transcriptomic signatures in pediatric brain tumors distinguish cancer from cancer-free control
2025Open Access
Supplementary Tables from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2025Open Access
Supplementary Figures from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2025Open Access
Supplementary Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2025Open Access
TIM3 blockade with hypomethylating therapy restores NK and cytotoxic CD4+ T cell activity in patients with AML or MDS
2025Open Access
Anti-TIM3 with hypomethylating agent revives NK and cytotoxic CD4+ T cell activity in patients with AML or MDS
Blood·2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
Cancer Research·2025Open Access
Cardiac magnetic resonance in heart transplant recipients: histological, clinical and cell-free DNA validation
European Heart Journal - Cardiovascular Imaging·2025· 1 citedOpen Access
Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypes
Science Advances·2025· 4 citedOpen Access
Challenging endomyocardial biopsies' gold standard status in rejection screening: a prospective blinded study on cardiovascular magnetic resonance in heart transplant patients
European Heart Journal·2024Open Access
Abstract A040 Tumor educated platelets in detecting pediatric central nervous system tumors
Cancer Research·2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses
Blood·2024· 10 citedOpen Access
Somatic mutations associate with clonal expansion of CD8 <sup>+</sup> T cells
Science Advances·2024· 3 citedOpen Access
Abstract A006: Cancer origin tracing and timing in two high risk prostate cancers using multisample whole genome analysis: Potential clinical value
Cancer Research·2024
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers
Immunity·2023· 56 citedOpen Access
Natural Killer Cells Are Active Against Myeloma, Leukemia or Lymphoma Cells with Loss of Tumor Suppressor Genes
Blood·2023Open Access
Clonal Hematopoiesis Associated with Rheumatoid Arthritis
Blood·2023· 5 cited
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
Genome Medicine·2023· 12 citedOpen Access
Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia
Leukemia·2023· 1 citedOpen Access
P-182 Natural killer cells are active against myeloma cells with loss of tumor suppressor genes
Clinical Lymphoma Myeloma & Leukemia·2023
page 1 of 10Next →

Frequent Co-authors

Satu Mustjoki(13), Teija Ojala(8), Soile Tynkkynen(7), Olli Dufva(7), Caroline A. Heckman(7), Petri Auvinen(6), Tero Aittokallio(6), Jani Huuhtanen(6), Bishwa Ghimire(6), Willem M. de Vos(5), Olli Kallioniemi(5), Akseli Hemminki(5), Johan Lundin(5), Nina Linder(5), Riku Turkki(5), Ari Ristimäki(5), Juuso Juhila(5), Timo Joensuu(5), Kerttu Koskenniemi(5), Kirsi Savijoki(5)